Abstract
A molecular environment that promotes vascularization around human carcinomas can materialise rapidly, and has been termed the angiogenic switch. Turning this switch toward a proangiogenic state involves an altered interplay between tumor cells and multiple components of the surrounding stroma. The regulatory landscape of these interactions in cervical cancer is now investigated by Huang et al. in this issue of Oncogene, who demonstrate that the microRNA miR-126 is downregulated during cancer progression, particularly in stromal cells. Such a reduction of miR-126 is shown to free at least one target, the proangiogenic adrenomedullin, from repression, enhancing vascular growth especially at the in situ to invasive carcinoma transition. The study implicates the temporal, spatial and progressive nature of tumor–stroma interactions during carcinogenesis, while in turn suggesting therapeutic strategies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646–674.
Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA . Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004; 56: 549–580.
Urbich C, Kuehbacher A, Dimmeler S . Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 2008; 79: 581–588.
Bartel DP . MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215–233.
Anand S, Cheresh DA . MicroRNA-mediated regulation of the angiogenic switch. Curr Opin Hematol 2011; 18: 171–176.
Huang T-H, Chu T-Y . Repression of miR-126 and up-regulation of adrenomedullin in the stromal endothelium by cancer-stromal crosstalks confers angiogenesis of cervical cancer. Oncogene 2013, (unpublished).
Guidi A, Abu-Jawdeh G, Berse B, Jackman RW, Tognazzi K, Dvorak HF et al. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst 1995; 87: 1237–1245.
Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008; 15: 261–271.
Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008; 15: 272–284.
Ribatti D, Nico B, Spinazzi R, Vacca A, Nussdorfer GG . The role of adrenomedullin in angiogenesis. Peptides 2005; 26: 1670–1675.
Zhu N, Zhang D, Xie H, Zhou Z, Chen H, Hu T et al. Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2. Mol Cell Biochem 2011; 351: 157–164.
Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ . MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA 2008; 105: 1516–1521.
Bhowmick NA, Moses HL . Tumor-stroma interactions. Curr Opin Genet Dev 2005; 15: 97–101.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
de Giorgio, A., Castellano, L., Krell, J. et al. Crosstalk-induced loss of miR-126 promotes angiogenesis. Oncogene 33, 3634–3635 (2014). https://doi.org/10.1038/onc.2013.317
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2013.317